[1]
Lukina, S.S., Zavarykina, T.M., Ivanova, N.A., Pronina, I.V., Kazubskaya, T.P., Kruglova, M.P., Ryabchikov, D.A., Loginov, V.I. and Burdennyy, A.M. 2020. The role of GSTP1 and MTHFR gene polymorphic markers in the decreased response to doxorubicin therapy of breast cancer patients. Patogenez (Pathogenesis). 18, 3 (Sep. 2020), 53-60. DOI:https://doi.org/10.25557/2310-0435.2020.03.53-60.